Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Dec, 7 2024
Sep, 4 2023
Oct, 6 2025
Oct, 25 2025
Jan, 30 2026